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     Self-assembling peptides have emerged as new nanobiomaterials and received considerable 
attention in the areas of nanoscience and biomedical engineering. One important type is the ionic-
complementary peptide, which contains special patterns of positive and negative charge 
distribution. This thesis explores the application of this special type of peptides for the 
modification of electrode surfaces. The ionic-complementary peptide modified electrode was 
then further used to immobilize biologically active molecules, glucose oxidase in the present case, 
to construct a biosensor. There are two major parts in this thesis. 
     In the first part, an ionic-complementary peptide, EFK16-II, was used to modify a highly 
ordered pyrolytic graphite (HOPG) electrode surface. The nanofibre structure of the self-
assembling peptide on the electrode surface was characterized by atomic force microscopy 
(AFM).  Attenuated total reflection fourier transform infrared sectroscopy (ATR-FTIR) spectra 
showed that upon addition of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC), EFK16-II 
molecules tend to be cross-linked among themselves. Cross-linking of the peptide diminishes the 
number of carboxyl groups available for immobilizing a sensing enzyme, i.e., glucose oxidase 
(GOx). A simple method based on pre-mixing the carbodiimide and GOx was developed; it 
inhibited peptide cross-linking and significantly improved enzyme immobilization. Biosensors 
constructed in this way showed increased overall signal intensity and a much higher sensitivity at 
4.94mA M-1 cm-2, a six-fold increase compared to the previously-reported peptide-modified 
electrodes.  
     In the second part, another ionic-complementary peptide, EAK16-II, was used to modify the 
HOPG electrode. AFM images showed that EAK16-II formed well-ordered nanofibre patterns on 
iv 
the electrode surface. The redox couple Fe(CN)63-/4- was used as a probe to detect the 
electrochemical properties of the EAK16-II modified electrode. The results showed that the 
electron transfer at the electrode surface does not change much before and after modification. 
GOx was immobilized onto the EAK16-II modified HOPG and showed a good response to the 
concentration change of glucose. Similar to the EFK16-II, inter- or intro-peptide cross-linking 
also occurs when the solution containing EDC and sulfo-NHS was injected onto EAK16-II 
modified electrode. The same method as in the first part was applied here to prevent peptide 
cross-linking. The sensitivity was improved from 0.53mA M-1cm-2 to 2.4mA M-1cm-2.  
     A proposal for constructing a reagentless biosensor by immobilizing both enzyme and 
mediator onto the electrode was made. However, the results indicated that the mediator, ferrocene 
carboxylic acid (FCA), was not stable on the surface after being immobilized. A redox protein, 
cytochrome c (Cyt c), was also immobilized onto an EAK16-II modified electrode. Direct 
electron transfer (DET) between the redox center of Cyt c and the electrode was observed. 
However, cyclic voltammetry results indicated that the peptide did not help improve the DET of 
modified Cyt c. 
     The results presented here demonstrate significant potential for ionic-complementary peptides 
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Chapter 1 Introduction 
1.1 Overview 
     Sensors are defined as devices that measure a physical quantity and convert it into a signal 
which can be read by an observer or by an instrument. Sensors exist all round the world, not only 
in technical and research fields, but also in our daily life. For example, a mercury thermometer is 
a sensor because the temperature causes the expansion and contraction of a liquid which can be 
read on a calibrated glass tube. 
    Rapid, reliable, inexpensive, and in some cases, continuous measurement of analytes has been 
the major goal in analytical sciences. Since biosensors offer many advantages over conventional 
analytical techniques, the development of biosensors for analytical purposes has attracted a great 
deal of interest in recent years. By definition, biosensors are analytical devices that combine a 
biologically sensitive element (bio-recognition agent) with a physical or chemical transducer (e.g., 
a noble metal or graphite electrode, optical fibers, surface acoustic wave or calorimetric devices) 
to selectively detect and measure the amount of specific compounds in a given external 
environment1. The bio-recognition agent is a bioactive substance, e.g., enzyme, antibody and 
micro-organism. These substances are capable of recognizing their specific analytes and also 
regulate the specificity and sensitivity of the device.  
     One of the advantages of biosensors is that they are highly selective. This is because the bio-
recognition agent is capable of recognizing a specific substrate and transferring concentration 
information of the substrate to the transducer. Biosensors offer the possibility of real-time 
analysis, important for the rapid measurement of body analytes. The application of biosensors 
usually lies in the clinical analysis for health care. 
2 
     The key element in the design of a suitable sensor architecture is the immobilization of a 
specific bio-recognition agent such as an enzyme on the transducer surface2. For this purpose, 
suitable surface linkers or matrices are therefore required to immobilize the enzyme on the 
surface and provide a biocompatible platform to allow the enzyme to function properly and 
effectively. The unique properties of the ionic-complementary peptides make them good 
candidates in biosensing application. First, these peptides usually have amphiphilic property, with 
both hydrophobic and hydrophilic parts in the molecular structure. Since most carbon-based 
electrodes are hydrophobic, the peptides have good affinity toward the electrode surface so that 
the electrodes can be modified by the peptides. Second, unlike other organic/inorganic materials, 
peptides consist of amino acids, which are contained in enzymes. Compared to organic/inorganic 
material modified surfaces, the peptide modified surfaces are more likely to be biocompatible and 
help maintain the bioactivity of the enzymes. Third, the ionic-complementary peptides follow 
some specific patterns and different peptides can easily be designed just by substituting the amino 
acid with another one having similar property. For example, the hydrophobic residues of the 
peptide can be substituted by other hydrophobic amino acids.  
     The main purpose of this study is to explore the application of ionic-complementary peptides 
in biomolecular sensing. Two typical ionic-complementary peptides, EAK16-II and EFK16-II, 
which contain the hydrophobic residues alanine (A) and phenylalanine (F), respectively, have 
been chosen for this study. These peptides also contain hydrophilic residues, glutamic acid (E) 





1.2 Research Objectives 
The objectives of this study are to: 
1. use the ionic-complementary peptide EFK16-II to construct a glucose biosensor; 
2. study the mechanism of the immobilization of the enzyme glucose oxidase (GOx) and 
methods to improve the signal intensity of the glucose biosensor; 
3. study the properties of the EAK16-II-modified HOPG electrode and explore its 
application in glucose concentration detection; 
4. study the immobilization of cytochrome c on the EAK16-II-modified electrode and its 





Chapter 2 Literature Review 
 
2.1 Definition and Classification of Biosensors 
 
2.1.1 Definition of Biosensors 
      A chemical sensor is a device that transforms chemical information, ranging from the 
concentration of a specific sample component to total composition analysis, into an analytically 
useful signal. Chemical sensors consist of two major parts: a chemical recognition system 
(receptor) and a physico-chemical transducer. Biosensors are chemical sensors in which the 
recognition system utilizes a biochemical mechanism.3,4 Figure 2.1 shows the general 
configuration of a biosensor. The biological recognition system translates information from the 
biochemical domain into a chemical or physical output signal with a high degree of selectivity. 
The transducer converts this chemical or physical signal into a measurable electronic signal.5 
Since biosensors offer many advantages over conventional analytical techniques in terms of 
simplicity, detection limit, specificity and sensitivity, the development of biosensors for 
analytical purposes has attracted significant interest in recent years. Biosensors have widespread 
applications in medical analysis, environmental monitoring and industrial process control.6-8  
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Figure 2.1 Schematic architecture of a biosensor 
2.1.2 Classification of Biosensors 
     Based on the types of transducer used, biosensors have been divided into optical, calorimetric, 
piezoelectric and electrochemical biosensors.  
 
2.1.2.1 Optical Biosensors  
      Optical biosensors are based on the measurement of light absorbed or emitted as a 
consequence of a biochemical reaction.9,10 One of the major advantages of optical sensors is their 
ability to probe surfaces and films in a non-destructive manner. Additionally, they offer 
advantages in speed, safety, sensitivity and robustness, as well as permitting in situ sensing and 
real-time measurements. Optical immunosensors are currently receiving attention as alternatives 
to conventional immunoassay techniques because of the promise of enhanced sensitivity and the 
elimination of expensive, complex and time-consuming separation and incubation procedures. An 
optical immunosensor consists of either an antibody or antigen immobilized on a suitable surface. 
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The primary function of this type of sensor is to produce a measurable signal (which can be 
followed optically) upon interaction with a biospecific immunological component. The signal 
amplitude is related to the amount of antibody, antigen or hapten present in the sample.11-13 
However, optical biosensors are very sensitive and they cannot be used in turbid media.  
 
2.1.2.2 Calorimetric Biosensors 
      Calorimetric biosensors detect an analyte on the basis of the heat evolved due to the 
biochemical reaction of the analyte with a suitable enzyme. Recently, integrated circuit 
temperature-sensitive structures have been modified with enzymes. Different substrates, enzymes, 
vitamins and antigens have been detected using thermometric biosensors. The most commonly 
used approach in the thermal enzyme probes is related to the enzyme directly attached to the 
thermistor.14,15 Calorimetric biosensors are not widely used, primarily because most of the heat 
evolved in the biochemical reaction is lost to the surroundings without being detected, leaving the 
sensor with a low sensitivity. 
 
2.1.2.3 Piezoelectric Biosensors 
       Piezoelectric biosensors operate on the principle of generation of electric dipoles on 
subjecting an anisotropic natural crystal to mechanical stress. Adsorption of the analyte increases 
the mass of the crystal and alters its basic frequency of oscillation. The use of piezoelectric 
transducers in biosensors was foreshadowed in the work of Sauerbrey who not only pioneered the 
use of the quartz crystal microbalance (QCM) but thoroughly analyzed the physics of the 
device.16 The concept was then extended to chemical sensing by applying suitable sorption 
detection coatings to a QCM to selectively detect gases17 and antibodies.18 Nowadays, many 
7 
other biological species such as ammonia, nitrous oxide, methane and certain organophosphorus 
compounds19,20 can be detected by piezoelectric biosensors.  
 
2.1.2.4 Electrochemical Biosensors 
      Electrochemical biosensors are the most commonly used class of biosensors. These are based 
on the fact that during many bio-interaction processes, electrons are consumed or generated 
producing an electrochemical signal which can in turn be measured by an electrochemical 
detector. Electrochemical biosensors are favored over optical sensors mainly because of cost and 
availability, while thermal biosensors can not be used in turbid media.21 Electrochemical 
biosensors can be operated in turbid media, have comparable instrumental sensitivity and are 
more amenable to miniaturization. Based on the electrochemical property that is measured by the 
detector system, electrochemical biosensors can be divided into conductometric, potentiometric 
and amperometric biosensors.  
     Conductometric biosensors measure the changes in the conductance between a pair of metal 
electrodes as a consequence of the biological component. Potentiometric biosensors measure 
potentials at the working electrode with respect to the reference electrode when zero or no 
significant current follows between them.22-24 For potentiometric measurements, the relationship 
between concentration and the potential is governed by the Nernst equation. Potentiometric 
sensors offer low detection limits for various ions such as Na+, K+, Ca2+, H+ and NH4+ and 
usually have no chemical influence on samples. 
     Amperometric biosensors measure the changes in the current passed by the working electrode 
due to the oxidation or reduction of the analyte on the electrode surface. The oldest bioanalytical 
application of amperometry is the measurement of dissolved oxygen concentration. It exploits a 
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gas-permeable membrane for selectivity, across which oxygen diffuses and is reduced at the 
electrode at a constant potential.25 The most important category of amperometric biosensors 
includes enzyme-based biosensors. The first enzyme biosensor was reported by Clark26 in 1962. 
This biosensor consists of glucose oxidase bound to a membrane covering an amperometric 
oxygen electrode. This was the first device that could be used to measure the concentration of an 
enzyme substrate without adding an enzyme as a reagent to the analyte solution. However, the 
oxidase-based devices rely on the use of oxygen as the physiological electron acceptor and are 
subject to errors due to fluctuations in the oxygen activity. Artificial electron acceptor known as a 
mediator is introduced as a substitute for oxygen and shuttles electrons from enzyme to the 
electrode. Ferrocene and its derivatives, ferricyanide, methylene blue, benzoquinone and N-
methyl phenazine etc. are the most commonly used mediators in biosensors.27-31 In addition, the 
application of mediator also allows the enzyme electrode to operate at a lower potential so that 
some interferences  such as ascorbic acid, uric acid and acetaminophen are not electroactive.32  
 
2.2 Materials Used for Electrode Modification 
      Electrochemical biosensors have emerged as the most commonly used biosensors. One 
typical kind of electrochemical biosensor utilizes enzyme-modified electrodes. The general 
configuration of an enzyme-based amperometric biosensor comprises an immobilized enzyme as 
the chemically selective layer, an electrode as transducer that is coupled to an amplifier, 
processor and the display33,34 as shown in Figure 2.2.  
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Figure 2.2 Basic elements of an enzymatic biosensor35 
 
 
          The immobilization of the enzymes on the electrode surface is considered as one of the 
most critical steps that dictates the effectiveness of these electrodes. Different chemical, 
biochemical or physical techniques, e.g., chemical crosslinking with glutaraldehyde or other 
bifunctinal agents,36,37 antigen-antibody interactions (e.g. based on avidin biotin binding),38 
magnetic interactions,39,40 entrapment or encapsulation within polymers41 and the formation of 
pasted materials42 have been exploited for this purpose.  
 
2.2.1 Self-assembled Monolayers (SAMs) 
     A self-assembled monolayer (SAM) is formed by the strong chemisorption between the 
substrate and head group of selected organic molecule.43,44 SAM provides one simple route to 
functionalize electrode surfaces by organic molecules (both aliphatic and aromatic) containing 
free anchor groups such as thiols, disulphides, amines, silanes or acids. The best characterized 
systems of SAMs are alkanethiolates X(CH2)nS- on gold.45,46 The formation of  such a SAM is 
10 
shown in Figure 2.3.47 The sulfur atoms form a commensurate overlayer on Au (111) with a 
tilting degree of 30°. The thickness of the monolayer is determined by the number of methylene 
groups (n) in the alkyl chain. The surface properties of the monolayer can be easily modified by 
changing the head group X.48 
 
Figure 2.3 Formation of SAM on gold surface47 
 
 
     In an amperometric sensor, a carboxylic acid terminated SAM [HS(CH2)nCOOH with n=15 or 
11] is used to immobilize cytochrome c via carbodiimide activation.49 A much bigger redox peak 
was found for covalently immobilized cytochrome c than electrostatically adsorbed cytochrome c. 
In addition, electrostatically driven adsorption is limited to low ionic strength solutions, because 
desorption occurs in high ionic strength solutions.50,51 Covalent attachment allows for the 
characterization of cytochrome c over a wide range of solution conditions. Also, self-assembled 
monolayers of ω-mercapto carboxylic acids, HS(CH2)nCOOH (n=2, 5, 10), on gold electrodes 
were applied to detect the neurotransmitter dopamine in the presence of ascorbic acid.52 At 
neutral pH, the negatively charged SAM repels ascorbic acid, while positively charged dopamine 
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can be detected at sub-millimolar levels. An optimum value of n for the detection is n=5. This is 
attributed to a compromise between a well-organized system that requires long ω-mercapto 
carboxylic acids and a reasonable rate of electron transfer which is observed with short ω-
mercapto carboxylic acids.  
     Redox enzymes linked to SAMs have been studied by Creager and Olsen.53 A glucose sensor 
is prepared by cross-linking glucose (GOx) to a ω-hydroxy alkanethiol SAM through glutaric 
dialdehyde. Electrical communication between electrode and GOx is achieved via freely 
diffusing hydroxymethylferrocene. Normally, redox currents are diminished by a SAM, but the 
response of this redox mediator was less affected. Background currents due to interferences (uric 
acid, ascorbic acid and 4-acetamidophenol) were dramatically reduced relative to untreated 
electrodes. Willner et al.54 achieved direct electron transfer by using a SAM-modified gold 
electrode. A roughened gold foil was first treated by cystamine to form a monolayer. This base 
monolayer was then reacted with pyrrploquinoline quinone (PQQ). After that, the resulting PQQ 
submonolayer was reacted with N-(2-aminoethyl)-FAD to yield a PQQ/FAD diad layer. Finally, 
apo-glucose oxidase was reconstituted on the PQQ/FAD monolayer-modified gold electrode. The 
process is shown in Figure 2.4. The enzyme layer in such an electrode provides efficient 
electrical contact with the electrode by PQQ redox relay and effectively stimulates the 
electrobiocatalyzed oxidation of glucose. The current increases linearly with increase of glucose 
concentration up to 80mM glucose. The current density attained is near the theoretical calculated 
value for a densely packed glucose oxidase monolayer.  
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Figure 2.4 Reconstitution of glucose oxidase onto a PQQ/FAD monolayer Au-electrode and 
direct electron transfer between glucose and the modified electrode54 
 
 
2.2.2 Electron-conducting Redox Hydrogels 
     Redox hydrogels constitute the only known electron-conducting phase in which the analyte 
(for example, glucose) and water-soluble ions dissolve and diffuse.55 Redox polymers are 
comprised of two parts: the cross-linked backbone and tethered redox center. One typical 
structure is shown in Figure 2.5. The advantage of redox hydrogels is that the redox mediator is 
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covalently linked to the insoluble, but water-swollen, cross-linked polymer-network of the gel 
and the enzyme is also trapped in the gel so that there is no leachable component.56-58  Another 
advantage is that multiple enzyme layers are connected to the electrodes and the attained current 
densities are usually about 10-fold higher or more than they are when enzyme monolayers are 
immobilized on the electrode surface. Mano et al.58 studied the effect of the content of osmium to 
the current density of the enzyme electrode. They prepared three polymers with the [tethered 
complex (containing osmium)/pyridine/carboxyl-pentylpyridinium] ratio for polymer I being 
10.7/85/4.3, for polymer II 12.8/85/2.2 and for polymer III 20/75/5. Compared with redox 
polymers I and III, the redox polymer II demonstrated the highest current density at 1.5 mA cm-2. 
Besides, the oxidation of glucose on the enzyme electrode prepared with polymer II exhibited the 
lowest overpotential.  
 
Figure 2.5 Structure of a redox polymer designed to electrically connect the reaction centers of 
glucose oxidase to electrodes55 
14 
      
      Redox hydrogels conduct electrons by self-exchange of electrons or holes between rapidly 
reduced and rapidly oxidized redox functions tethered to backbones of cross-linked polymer 
networks. Although the networks, which are formed by cross-linking of water-soluble redox 
polymers, swell in water, they do not dissolve. The redox polymers conduct electrons, or holes, 
through self-exchange in water swollen hydrogels.59 Because electron transfer by self-exchange 
requires collisions between reduced (electron-loaded) and oxidized (hole-loaded) redox 
centers,59,60 electron transfer slows when an overwhelming majority of the redox centers are 
either oxidized or reduced. Another factor that affects the electron transfer rate is the spacers that 
connect the redox centers to the cross-linked networks. The long and flexible spacers increase the 
distance over which the tethered redox centers move about. In this way, more effective 
transferring collisions or faster electron transfer are achieved. The optimum spacers have lengths 
between 10 and 15 atoms.57,61  
     In a glucose biosensor, four electron transfer steps occur as shown in Figure 2.6. The electrons 
flow from glucose to the enzyme molecules (1), from the enzyme molecules to the redox polymer 
(2), through the redox polymer (3) and from the polymer to the anode (4). Thus, another 
important aspect in the redox hydrogel is the electron transfer between the enzyme and the 
tethered polymer. This is enabled by motion of the tethered segments of the cross-linked redox 
polymer network. After reacting with glucose, the redox center of glucose oxidase, FAD is 
reduced to FADH2. It was then oxidized to FAD by collision with the tethered segments.  
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Figure 2.6 The electron transfer path in a glucose biosensor 
 
 
     Koide et al.62 has studied the use of a ferrocene-containing polymer. The structure of this 
polymer is shown in Figure 2.7. Polyallylamine was cross-linked with glutaraldehyde and 
modified successively with ferrocenecarboxylic acid. GOx and the redox hydrogel were 
immobilized on the glassy carbon electrodes by using glutaraldehyde. They found that swelling 
of the redox polymer caused a decrease of the redox current because this increased the distance 
between the redox sites of the polymer and slowed down electron transfer rate among 
neighboring redox sites. However, by adding bovine serum albumin (BSA) into this polymer, 
excessive swelling could be prevented and the redox polymer maintained its original redox 
current even after 5 h of soaking. The linear range between current and glucose concentration 
extends as far as 7mM.  
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Figure 2.7 Structure of ferrocene-containing cross-linked polyallylamine62 
 
 
2.2.3 Carbon Nanotubes and Other Nanomaterials 
     Carbon nanotubes (CNT) discovered by Iijima in 199163 have gained considerable attention in 
recent years because of their remarkable electronic and mechanical properties, which have made 
them extremely attractive for a wide range of sensing applications from structural materials64 to 
nanoelectronic components.65 One advantage of the application of CNT in biosensing is direct 
electron transfer. Cai et al.66 studied the direct electron transfer of glucose oxidase promoted by 
multi-walled carbon nanotubes. CNT was first dispersed in a solution of surfactant, 
cetyltrimethylammonium bromide (CTAB). Then, this CNT suspension was mixed with GOx, 
thus caused the physical adsorption of GOx molecules onto the surface of CNT during mixing. 
An aliquot of this mixture was cast onto glassy carbon electrode surface and dried. Finally, 
Nafion was used as a binder to hold the GOx-CNT on the electrode surface stably. Cyclic 
voltammograms of this Nafion-GOx-CNT/GC electrode in 0.1M PBS (pH 6.9) at a scan rate of 
40mV/s showed a pair of well-defined and nearly symmetric redox peaks (Figure 2.8). From the 
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dependence of ΔEp on the scan rates, the apparent heterogeneous electron transfer rate constant, 
ks, was calculated to be 1.53±0.45s-1.  
 
Figure 2.8 Cyclic voltammograms of the the Nafion-CNT/GC (a) and Nafion-GOx-CNT/GC (b) 
electrode in 0.1M PBS (pH 6.9) at a scan rate of 40mV/s. The arrows denote the scan direction.66 
 
 
     Gooding et al.67 presented a strategy for studying the electron transfer properties of redox 
enzymes such as microperoxidase 11 attached to the end of aligned single-walled carbon 
nanotubes (SWCNT). Rather than coating the electrode surface by a random tangle of 
nanotubes,68-73 SWNTs were aligned on the electrode surface. A polycrystalline gold electrode 
was first activated by cystamine to form a cystamine self-assembled monolayer (SAM). This 
electrode was further treated by shortened SWCNTs in DMF containing 
dicyclohexylcarbodiimide to convert the carboxyl group located at the end of the shortened 




surface. Finally, microperoxidase was attached to the free ends of the tubes by incubation in a 
microperoxidase solution at 4°C overnight. This process is shown in Figure 2.9. The SWCNTs 
aligned on the electrode surface were able to wire electron transfer between the protein and gold 
electrode. 
 
Figure 2.9 Scheme of the different steps involved in a fabrication of aligned shortened SWCNT 
arrays for direct electron transfer of microperoxidase MP-1167 
 
 
     A similar strategy was used by Patolsky et al.74 for constructing a glucose biosensor. A 2-
thioethanol/cystamine mixed monolayer (3:1 ratio) was assembled on a gold electrode and the 
SWCNTs were attached to the surface in the presence of the coupling reagent 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide hydrochloride (EDC) as depicted in Figure 2.10. The amino 
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derivative of the FAD cofactor was then coupled to the carboxy groups at the free edges of the 
standing SWCNTs. Finally, apo-GOx was reconstituted on the FAD units linked to the ends of 
the standing SWCNTs. The result demonstrated that the SWCNTs act as nanoconnectors that 
electrically connect the active site of the enzyme and the electrode. The electron transfer rate is 
controlled by the length of the SWCNTs. The longer the nanotube is, the slower is the transfer 
rate. This enzyme electrode also showed good capability for glucose sensing and has a detection 
range as high as 160mM glucose.  
 
Figure 2.10 Fabrication process for electrically wiring glucose oxidase to a nanotube electrode74 
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     Yemini et al.75,76 explored the use of peptide nanotubes (PNT) in biosensors. Dipeptide 
phenylalanine-phenylalanine (FF) was found to form nanotube structures. The diphenylalanine-
based peptide nanotubes have many advantages as they are biocompatible, can be easily modified 
with biological and chemical elements,77-79 and show a notable similarity to carbon nanotubes in 
their morphology and aspect ratio. The PNT was first used to modify screen printed electrodes. 
Ferri/ferrocyanide was used as a probe to test the electrochemical properties of the PNT-modified 
electrodes. Cyclic voltammograms showed that after modification, the redox current for 
K4[Fe(CN)6]/K3[Fe(CN)6] increased about 2-fold. The difference between Epa and Epc decreased 
from 0.14V for unmodified screen printed electrodes to 0.07V for PNT-modified electrodes. 
These results indicate that the presence of peptide nanotubes significantly improved the 
electrochemical fingerprint of the electrode. This peptide nanotube-modified electrode was then 
further tested for the application of H2O2 sensing. Again, a much higher current response was 
obtained with the PNT-modified electrode than the bare screen-printed electrode.  
     The peptide nanotubes have also been modified by a thiol group and used to modify a gold 
electrode.76 This modified gold electrode showed a good amperometric response to detect 
hydrogen peroxide and NADH. The high electrocatalytic activity of PNT modified electrode is 
likely due to the direct electron transfer between the spatially aligned aromatic systems that 
contribute to the electronic conductivity of the assemblies. Furthermore, GOx was immobilized 
onto the PNT-modified gold electrode and showed a linear amperometric response upon 
successive addition of 0.2mM glucose. 
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2.3 Peptide Self-assembly 
     Self-assembly is defined as the process whereby individual components spontaneously 
organized into an ordered structure without any artificial intervention.80 The mechanism behind 
the self-assembly phenomena is weak, non-covalent interactions between individual elements. 
Self-assembly peptides have been extensively studied during the last decade. There are 20 natural 
amino acids that are the building blocks for various peptides. The easy preparation and 
purification of short peptides makes them very useful for peptide design and studying of the 
relationship between their molecular structure and physiochemical properties. Several types of 
self-assembly peptides are reviewed in the following sub-sections.  
 
2.3.1 Amphiphilic and Surfactant Peptides 
     The traditional surfactant contains a hydrophobic region and a separate hydrophilic region that 
can self-assemble into distinct structures such as micelles, vesicles and tubules. The driving force 
is mostly that the hydrophobic part of the surfactant tends to avoid the water phase and 
approaches the hydrophobic part of the other surfactant molecules. The same idea can be used for 
the design of amphiphilic peptides. Zhang’s group from MIT has done a lot of work on the 
amphiphilic peptides.81-85 These peptides share a common motif: the polar region of each 
molecule has one or two charged amino acids and the non-polar region is made from four or more 
consecutive hydrophobic amino acids.  
     One example84 is V6D with the sequence of VVVVVVD (V denotes valine and D denotes 
aspartic acid). It has a hydrophilic head of negatively charged aspartic acid (D) containing 
another negative charge from the C terminus. The hydrophobic tail contains six valines (V) and 
the N terminus is acetylated, making it uncharged. From dynamic light scattering (DLS) test, this 
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peptide self-assembles into 30-50nm structures when dissolved in water. In order to determine 
the real structure of the peptide formed in aqueous solution, a transmission electron microscopy 
(TEM) study of the flash-frozen samples was conducted. The result is shown in Figure 2.11. 
Nanotube structures with approximately 30-50nm diameters that are several microns long are 
clearly seen from the TEM images. Nanovesicles were also observed, suggesting that dynamic 
behavior of the supramolecular assemblies may be tunable by changing the environment and the 
sequence of the monomer.  
 
Figure 2.11 The TEM images of V6D. The sample was flash-frozen in liquid propane (-180°C) 
and surface-coated with a thin layer of platinum and carbon, yielding a replica to preserve the 
structures formed in solution.84  
 
 
A proposed pathway for the formation of this supramolecular structure of nanotubes is 
shown in Figure 2.12. The peptide monomers form small segments of the bilayer ring, with 
hydrophobic tails packing together to avoid water and hydrophilic heads exposed to water on the 
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inner and outer portion of the tube. Through continuous dynamic energy minimization, they grow 
into single subunit rings and multirings, in which aspartic acid hydrophilic groups remain 
exposed to the continuous aqueous medium. The tubular arrays may subsequently stack through 
noncovalent interactions to form longer nanotubes.  
 
Figure 2.12 Potential pathway of V6D peptide nanotube formation. Each peptide monomer is 
2nm, and the diameter of the modeled bilayer nanotube is 50nm. Red, hydrophilic head; blue, 
hydrophobic tail. Each peptide may interact with one another to form closed rings, which in turn 
stack on top of one another, ultimately yielding a nanotube. Three nanotubes are connected to 
each other through a three way junction.84 
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Figure 2.13 Structure of PA486 
 
 
     Hartgerink et al.86 designed a series of peptide-amphiphiles (PAs) and studied their self-
assembly properties in aqueous solution. The PAs are listed in Table 2.1. The structure of one of 
these PAs, PA4, is shown in Figure 2.13. They found that the self-assembly of PAs is sensitive to 
pH. When the pH of the solution is neutral, the PAs are negatively charged so that the peptide 
molecules repel each other and self-assembly of PAs is suppressed. Upon acidification, the 
negative charges are eliminated and the hydrophobic tails begin to aggregate. However, this 
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aggregation of the hydrophobic tails is also dictated by the length of the tails. PA1 does not self-
assemble because the tails are not long enough so that the hydrophobic interaction is not strong 
enough to induce self-assembly. PAs 3-5 have sufficiently long hydrophobic tails to make the 
cylindrical packing the most favorable. However, if PAs 3-5 are oxidized and form 
intramolecular disulfide bonds, the formation of nanofibers is not observed, indicating that 
conformational changes induced by these disulfide bonds suppress self-assembly. The assembly 
of PA4 can be triggered by pH. At pH4, it can form nanofiber networks with fibers that are ~7nm 
in diameter and several microns in length. These nanofibers can direct the growth of 
hydroxyapatite crystals, mimicking the function of collagen fibers in bone tissue. A three-amino 
acid moiety of arginine-glycine-aspartic acid (RGD) is attached to the carboxy-terminal of the 
peptide since this sequence has been found to be important in cell adhesion. Its incorporation into 
the system may promote cellular adhesion and overall biocompatibility.87  
     Cyclic peptides consist of six or eight amino acids with alternating D- and L- enantiomers. By 
means of elegant structural design, they can stack into nanotubes (Figure 2.14).88,89 The stack of 
the peptides is dependent on pH based on their amino acid sequences. The stacking can be 
controlled by selective protonation of the amino acid residues on each cyclic peptide disk at 
different pH values.89 This peptide system demonstrates some important applications for 
nanobiotechnology. First, assembled nanotubes could be used as an antibacterial agent since they 
act preferentially on bacterial membranes to increase their permeability and collapse 
transmembrane ion potentials. Furthermore, these actions lead to cell death. Second, the physical 
properties of the nanotube interiors can be modified by introducing heterocyclic alterations that 
allow for the passive transportation of small molecules.  
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Figure 2.14 Self-assembly of eight-residue cyclic D,L-α-peptides into nanotubes. The self-
assembly of the eight residue cyclic D,L-α-peptides with a flat and ring-shaped conformation is 
directed by backbone-backbone hydrogen bonding to give β-sheet-like tubular supramolecular 
structures. These nanotubes are open-ended and hollow.88  
 
 
2.3.2 Ionic-complementary Peptides 
     Along with the development of peptide amphiphiles and surfactant-like peptides, ionic-
complementary peptides have emerged as promising materials for many biomedical applications. 
Ionic-complementary peptides are characterized by an alternating arrangement of negatively and 
positively charged residues. There are certain patterns of charge distribution that the peptides 
should follow so that the sequence can have ionic-complementary property. The most simple and 
widely used patterns are type I (- +), type II (- - + +) and type IV (- - - - + + + +). The major force 
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that promotes peptide self-assembly in this case is electrostatic interactions. The various ionic-
complementary peptides that have been studied are listed in Table 2.2. 
 
Table 2.2 The list of ionic-complementary peptides90-92 
Name Sequence Charge Distribution Type Structure
P11-I n-QQRQQQQQEQQ-c ＋－ I α/β 
P11-II n-QQRFQWQFEQQ-c ＋－ I α/β 
P6-1 n-KTVIIE-c ＋－ I β/r.c. 
P6-6 n-KTVLIE-c ＋－ I β/r.c. 
P6-7 n-KTVIVE-c ＋－ I β/r.c. 
P6-8 n-KTVIYE-c ＋－ I r.c. 
Aβ16-22 n-KLVFFAE-c ＋－ I α/β/r.c. 
KADA8-I n-KADAKADA-c ＋－＋－ I r.c. 
KFE8-IT n-KFEFKFEF-c ＋－＋－ I β 
KFE8-I n-FKFEFKFE-c ＋－＋－ I β 
RADA8-I n-RADARADA-c ＋－＋－ I r.c. 
RAEA8-I n-RAEARAEA-c ＋－＋－ I r.c. 
EFK8-I n-FEFKFEFK-c －＋－＋ I β 
EAKA8-I n-AEAKAEAK-c －＋－＋ I r.c. 
KFE12-I n-FKFEFKFEFKFE-c ＋－＋－＋－ I β 
KIE12-I n-IKIEIKIEIKIE-c ＋－＋－＋－ I β 
KVE12-I n-VKVEVKVEVKVE-c ＋－＋－＋－ I β 
KLD12-I n-KLDLKLDLKLDL-c ＋－＋－＋－ I β 
KLE12-I n-KLELKLELKLEL-c ＋－＋－＋－ I β 
EFK12-I n-FEFKFEFKFEFK-c －＋－＋－＋ I β 
RADA16-I n-RADARADARADARADA-c ＋－＋－＋－＋－ I β 
RGDA16-I n-RADARGDARADARGDA-c ＋－＋－＋－＋－ I r.c. 
RAEA16-I n-RAEARAEARAEARAEA-c ＋－＋－＋－＋－ I β 
KADA16-I n-KADAKADAKADAKADA-c ＋－＋－＋－＋－ I β 
KFE16-I n-FKFEFKFEFKFEFKFE-c ＋－＋－＋－＋－ I β 
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EAKA16-I n-AEAKAEAKAEAKAEAK-c －＋－－－＋－＋ I β 
RAD8-II n-RARADADA-c ＋＋－－ II r.c. 
EAH8-II n-AEAEAHAH-c －－＋＋ II r.c. 
ELK8-II n-LELELKLK-c －－＋＋ II β 
EAK8-II n-AEAEAKAK-c －－＋＋ II r.c. 
EAK12-a n-AKAKAEAEAKAK-c ＋＋－－＋＋ II r.c. 
RAD16-II n-RARADADARARADADA-c ＋＋－－＋＋－－ II β 
EAH16-II n-AEAEAHAHAEAEAHAH-c －－＋＋－－＋＋ II β 
EFK16-II n-FEFEFKFKFEFEFKFK-c －－＋＋－－＋＋ II β 
ELK16-II n-LELELKLKLELELKLK-c －－＋＋－－＋＋ II β 
EAK16-II n-AEAEAKAKAEAEAKAK-c －－＋＋－－＋＋ II β 
KAE16-IV n-KAKAKAKAEAEAEAEA-c ＋＋＋＋－－－－ IV β 
RAD16-IV n-RARARARADADADADA-c ＋＋＋＋－－－－ IV β 
EAK16-IV n-AEAEAEAEAKAKAKAK-c －－－－＋＋＋＋ IV β 
DAR16-IV n-ADADADADARARARAR-c －－－－＋＋＋＋ IV α/β 
DAR16-IV T n-DADADADARARARARA-c －－－－＋＋＋＋ IV α/β 
DAR32-IV n-(ADADADADARARARAR)2-c －－－－＋＋＋＋ IV α/β 
EAK12-b n-AKASAEAEAKAK-c ＋－－＋＋ N/A r.c. 
EAK12-c n-AKAEAEAEAKAK-c ＋－－－＋＋ N/A r.c. 
EAK12-d n-AEAEAEAEAKAK-c －－－－＋＋ IV/II α/β 
Note: β: β-sheet; α: α-helix; r.c.: random coil; N/A: not applicable. 
     Ionic-complementary peptides have some unique characteristics. First of all, their charge 
distribution can be altered by the design of the sequence. For example, using the same amino 
acids (E, A and K) as the building blocks, three typical peptides can be designed, EAK16-I, 
EAK16-II and EAK16-IV (see Table 2.2). The difference in the charge distribution types can 
influence the peptide secondary structure and therefore its self-assembly.  
     A second feature, particular to the ionic-complementary peptides first studied by Zhang et al, 
is the specific chain lengths required to exhibit ionic complementary. The length of these peptides 
varies from eight to thirty-two amino acids in sequence due to alternating hydrophobic and 
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hydrophilic residues in the peptide sequence. The minimum number of amino acids required to 
build type I peptides is four, while type II and type IV require eight and sixteen amino acids, 
respectively.  
     A third feature is that the ionic-complementary peptide family can be easily expanded with the 
same charge distribution by using different amino acids. For example, starting from EAK16-II, 
many other similar peptides can be derived. Glutamic acid (E) can be replaced by aspartic acid 
(D), which is also negatively charged at neutral pH; on the other hand, lysine (K) can be replaced 
by arginine (R), which is positively charged at neutral pH. The hydrophobic residue of EAK16-II, 
alanine (A), can also be replaced by hydrophobic amino acids such as phenylalanine (F) and 
leucine (L). Such simple replacement maintains the intrinsic properties of ionic-complementarity 
and self-assembly.  
     Ionic-complementary peptides are promising molecules for material engineering because they 
can form stable nano/microstructures. In order to regulate its nano/microstructure, the 
understanding and precise control of peptide self-assembly is always a big challenge for material 
scientists. Using EAK16s as model peptides, our group has conducted a large amount of research 
toward controlling its self-assembly. The details will be discussed in the following. 
 
Sequence effect on self-assembly 
     Peptide sequence serves as an internal factor that tunes their self-assembly. The type, number 
and arrangement of amino acids in the sequence are extremely important in determining the 
secondary structures and self-assembly of the peptides. Each amino acid component has its own 
propensity to form a specific secondary structure. In addition, the periodicity of hydrophobic and 
hydrophilic amino acid residues can affect the secondary structure of a peptide.  
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      Hong et al.93 reported the effect of amino acid sequence on the nanostructure of self-
assembling peptides. They investigated the nanostructure formed by EAK16-II and EAK16-IV at 
different pH values, using atomic force microscopy (AFM). EAK16-II and EAK16-IV have the 
same amino acid components but different charge distributions, resulting in different polarities. 
The AFM images showed that EAK16-II formed well-defined fiber networks, whereas EAK16-II 
formed globular nanostructures at neutral pH (Figure 2.15).  Further investigation showed that 
EAK16-II formed fibril assemblies when prepared at pH values between 4 and 11, where 
EAK16-IV formed globular assemblies only near neutral pH (pH 6.5-7.5). When prepared above 
pH 7.5 or below pH 6.5, EAK16-IV formed fibril assemblies that were indistinguishable from the 
fibrils formed by EAK16-II. Surface tension studies suggested that there is a significant 
correlation between peptide nanostructure and surface activity. The globular EAK16-IV 
assemblies have lower surface tension, indicating a higher hydrophobicity than the fibril EAK16-
II assemblies. This could be due to the bending of EAK16-IV via strong intramolecular 
electrostatic attraction to form β-turns, exposing hydrophobic residues to the solution and 
lowering the surface tension. On the other hand, EAK16-II prefers a stretched β-strand, resulting 
in linear fibrils. 
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Figure 2.15 AFM images of EAK16-II (A) and EAK16- IV (B). The scale bars are 200nm.93 
 
 
Concentration effect on self-assembly 
     Another factor that affects self-assembly is peptide concentration. Since the peptide has a 
structure containing both hydrophobic and hydrophilic residues, the concentration dependence of 
peptide self-assembly is expected to be similar to that of surfactants. The micelle formation of 
surfactants has a critical micelle concentration (CMC). Similarly, one may anticipate that the 
peptides would be dispersed in a solution below a critical aggregation concentration (CAC) and 
begin to aggregate at or above this concentration. A CAC has been reported for many proteins 
and amphiphilic pepties.94-97 Alzheimer’s Aβ peptides have a CAC of 25μM at neutral pH96,97 and 
100μM in 0.1M HCl.97  
     Fung et al. found EAK16-II has a CAC value of ca. 60μM.98 The experiment was conducted 
by measuring the surface tension of peptide solution at different concentrations. The equilibrium 
surface tension was plotted against the peptide concentration and a transition state found to occur 
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at around 60μM, corresponding to the CAC. AFM studies of the nanostructure of EAK16-II 
revealed that isolated filaments and globules form below CAC while fibril network forms above 
CAC. In addition, the fibril size and network density are also dependent on the concentration. 
Another peptide EAK16-I was also investigated and the CAC was found to be 180μM.99  
 
pH effect on self-assembly 
     pH and salt concentrations are two significant factors in determining protein and peptide 
structures in biological systems. Since the peptides are composed of different amino acids, the 
change in solution pH can affect the ionic state of some amino acids as well as the net charges of 
peptides. This further influences the self-assembly behaviour because amino acid charges play an 
important role in determining the aggregation of the peptides. For example, polylysine undergoes 
structural changes from an α-helix to a β-sheet above pH 10 when the lysine residues became 
protonated100,101. This conformational change is reversible when the pH is lowered. Similarly, the 
β-amyloid peptide also goes through a structural change when the pH changes. It forms β-sheet 
structures at pH 5.4 and helical structures at pH 3 or 8.3101. These results suggest that the charge 
state of amino acid is critical to the secondary structure of peptides.  
     The nanostructure of ionic-complementary peptides was studied by Hong et al.93 using AFM. 
Interestingly, they found that the dependence of nanostructure on pH changes is different 
according to the peptide charge distribution. EAK16-IV formed globular structure at pH between 
6.5 and 7.5, while nanofiber structures appear at pH below 6.5 or above 7.5. In contrast, EAK16-
II formed fibril nanostructures throughout the pH range from 4 to 11. These finding suggest that 
the charge distribution in sequence plays an important role in determining the self-assembled 
peptide nanostructures. For a type IV charge distribution, strong intramolecular electrostatic 
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attractions occur at neutral pH and result in globular nanostructures. At extreme pHs such as pH 4 
and 11, either glutamic acid or lysine residues are neutralized. Therefore, intramolecular 
electrostatic interaction is weakened and insufficient to cause the peptide to form globular 
assembly. Thus, nanofiber formation will be predominant.  
 
Salt effect on self-assembly 
     The presence of salt affects the conformation and properties of many biological molecules, 
including their stability, solubility and biological activity102. The self-assembly of biomolecules 
is affected by salt concentration, valency of the salt, or even replacement of one type of salt with 
another of the same valency103.  Chen et al. reported the effect of salts on peptide self-assembly99. 
The CAC of EAK16-I increased in the presence of salts. Surface tension and AFM measurements 
showed that EAK16-I has a CAC of about 0.3mg/ml in water. In the presence of 20mM NaCl, the 
critical aggregation concentration of the peptide increased to 0.8mg/ml. The reason for this 
phenomenon is still not clear. De al Paz and colleagues found NaCl has significant effect on 
amyloid fibril formation104. By incubating the peptide in salt solution, they found that over the 
NaCl concentration range of 0-0.1M, the rate of fibril formation increased with ionic strength. At 
higher concentrations (>0.1M), only short filaments and amorphous aggregates could be 
observed. 
 
Surface effect on self-assembly 
     Molecular assembly at a surface plays an important role in many nanotechnology and 
biological applications. The effect of surface on the self-assembly of peptides and proteins has 
been explored in a variety of nanosystems. For example, the negatively charged virus M13 can 
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spontaneously form ordered monolayer structures on the surface of a positively charged, 
multilayered LPEI/PAA polymer film105. In another example, a hydrophobic graphite surface was 
reported to direct molecules, such as peptides106-108 and polymers109 to organize into various 
patterns. Yang et al.110 reported the self-assembly of ionic-complementary peptide EAK16-II on a 
mica surface. In-situ AFM was used as a main tool to observe the self-assembly of EAK16-II on 
this surface. Through real-time observation of EAK16-II nanofiber growth on mica, it was found 
that the nanofiber growth follows a nucleation and growth mechanism. The nanofiber “seeds” or 
fiber clusters formed in stock solution first adsorb on mica surface and serve as nuclei; this is 
followed by fiber elongation at the active ends of these nuclei. In addition, dynamic light 
scattering experiments showed that nanofibers no longer growing in solution can start to grow 
once they adsorb onto the surface and indicate that the nanofiber growth is a surface-assisted 
phenomenon. A proposed model is shown in Figure 2.16. Further research found that the growth 
rate of nanofiber can be regulated by adjusting the solution pH. The growth rate in different 
solutions follows the order: pure water > 1mM HCl > 1mM NaOH >10mM HCl ≈ 10mM NaOH 
≈ 0.  
 
Figure 2.16 Proposed model of EAK16-II nanofiber growth on mica110 
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Chapter 3 Improved Enzyme Immobilization on an Ionic-




      Biosensors are devices that are comprised of a biologically sensitive element (bio-recognition 
agent) and a transducer so as to transform chemical information (e.g., concentration of specific 
compounds) into an analytically useful signal.1,5 Among various biosensors, glucose biosensors 
have emerged as one of the most intensely studied because glucose detection is essential for both 
blood sugar monitoring of diabetes patients111 and quality control in food processing industries112. 
Since Clark and Lyons first proposed the initial concept for glucose enzyme electrodes113 in 1962, 
tremendous efforts have been directed towards their development with upgraded sensitivity and 
stability54,55,66,114,115.  
      One essential step in the fabrication of an amperometric glucose biosensor is the 
immobilization of an enzyme, which is usually glucose oxidase (GOx)116, onto the surface of 
electrodes. For this purpose, various materials have been used, such as polymers117, sol-gels118 
and self-assembled monolayers (SAMs)119. With recent developments in nanotechnology and 
bio-materials, researchers have begun to use peptide-modified electrodes for enzyme 
immobilization. Yemini el al. 75 reported a novel electrochemical biosensing platform based on 
self-assembled diphenylalanine (FF) peptide nanotubes. They demonstrated that the Fe(CN)64-
/Fe(CN)63- redox couple was more reversible and exhibited higher anodic/cathodic peak currents 
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on peptide nanotube-modified electrodes. Their research76 further showed that peptide nanotube-
modified gold electrodes can be used to immobilize GOx for glucose detection. However, the 
peptide nanotube based biosensor had a low sensitivity compared to other glucose biosensors. In 
addition, the storage stability of this kind of biosensor remains a serious problem. A collagen-like 
peptide modified gold electrode has also been studied for enzyme immobilization in biosensors120, 
whereby horseradish peroxidase (HRP) was covalently immobilized for H2O2 detection. The 
peptide layer on the electrode surface not only provided functional groups for enzyme 
immobilization, but also provided a biocompatible environment. However, this sensor also had 
the problem of low sensitivity.  
       In previous work done by our research group, Yang et al.121 demonstrated that ionic-
complementary, self-assembling peptides can be applied to the immobilization of GOx and the 
fabrication of a glucose biosensor. Similar to the collagen-like peptide layer, this unique ionic-
complementary peptide assembly also provides both functional groups and a biocompatible 
environment. To further develop applications for ionic-complementary peptides in biosensing, we 
present in this work a method for improving enzyme immobilization and thus achieving 
increased sensitivity of the sensor. 
      A typical ionic-complementary peptide EFK16-II was used in this study. Its molecular 
structure is shown in Figure 3.1. Two different methods for the immobilization of the enzyme 
GOx on the peptide modified HOPG electrode were compared. The first method is that described 
by Yang et al121. The peptide-modified HOPG electrode was first activated by a carbodiimide 
agent. Then enzyme was then immobilized onto this activated surface. However, cross-linking of 
the peptide was suspected to occur during the activation process, so that fewer active enzyme 
molecules were likely to be immobilized. In the second immobilization method, the peptide-
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modified HOPG electrode was not activated by carbodiimide. Instead, the carbodiimide was 
initially mixed with the enzyme in a buffer solution and this solution was injected onto the 
peptide modified HOPG surface for enzyme immobilization. This small change in the process 






Figure 3.1 Molecular structure of EFK16-II. The amino acid sequence is 
FEFEFKFKFEFEFKFK. The lower side is hydrophobic due to the phenylalanine (F) residues; 
the upper side is hydrophilic due to the glutamic acid (E) and lysine (K) residues. 
 
 
3.2 Materials and Methods 
3.2.1 Materials 
     The ionic-complementary peptide FEFEFKFKFEFEFKFK (EFK16-II) was purchased from 




F, E and K denote phenylalanine glutamic acid and lysine, respectively. The N-terminus and C-
terminus of the peptide were protected by acetyl and amino groups, respectively. 
      Highly ordered pyrolytic graphite (HOPG, 1cm×1cm) was obtained from SPI Supplies 
(West Chester, PA, USA). Glucose oxidase (GOx) from Aspergillus niger, glucose, 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide (EDC), sulfo-N-hydroxysulfosuccinimide (sulfo-NHS), 
ferrocenecarboxylic acid (FCA), K2HPO4 and KH2PO4 were all purchased from Sigma-Aldrich 
(Oakville, ON, Canada). All solutions were prepared using Milli-Q water (resistivity ≥
18MΩ·cm). 
 
3.2.2 Preparation of the Peptide-Modified HOPG Electrode 
      A freshly cleaved HOPG electrode was covered with 100μl of 0.5mg/ml EFK16-II stock 
solution and incubated overnight to have peptide modification on the graphite surface. The 
electrode surface was then washed with Milli-Q water three times to remove loosely attached 
EFK16-II. 
 
3.2.3 Enzyme Immobilization on the Peptide-Modified HOPG Electrode 
      Two immobilization methods were used and compared in this study. In the first method121, 
100μl of 50mM potassium phosphate buffer (pH 5.5) containing 2mM EDC and 5mM sulfo-NHS 
was injected onto the EFK16-II modified HOPG electrode surface. The electrode was left for 1h 
to convert carboxylate groups of EFK16-II into their sulfo-NHS ester. The electrode was then 
washed with 100μl of 50mM potassium phosphate buffer (pH 5.5) three times and immediately 
covered with 100μl of 50mM potassium phosphate buffer (pH 5.5) containing 1mg/ml GOx, and 
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incubated overnight at 4°C. The enzyme electrode (Method 1 GOx electrode) was then rinsed 
with a potassium phosphate buffer (pH 7.0) and used immediately.  
      In the second method, 100μl of 50mM potassium phosphate buffer (pH 5.5) containing 2mM 
EDC, 5mM sulfo-NHS, 1mg/ml GOx was injected onto the peptide modified HOPG electrode 
surface and then incubated overnight at 4°C. The electrode (Method 2 GOx electrode) was then 
rinsed with a potassium phosphate buffer (pH 7.0) and used immediately. The second method is 
more convenient and more efficient in terms of GOx immobilization, which will be investigated 
in more detail in section 3.3. 
 
3.2.4 Atomic Force Microscopy (AFM) 
      The structure of the peptide-modified HOPG surface was investigated by a PicoScanTM AFM 
(Molecular Imaging, Phoenix, AZ). To prepare the AFM samples, 100μl of 0.5 mg/ml EFK16-II 
stock solution was injected onto a freshly cleaved HOPG surface and incubated for 3h. It was 
then washed 3 times with Milli-Q water and left dry for 1-2 h. Silicon crystal tips (type NCL, 
NanosensorsTM) with a radius of 10nm were used for AFM tapping mode imaging. The AFM tip 
resonance frequency for imaging was between 160 and 180 kHz.  
 
3.2.5 Attenuated Total Reflection Fourier Transform Infrared Spectroscopy (ATR-FTIR) 
      Attenuated total reflection fourier transform infrared spectroscopy measurements were carried 
out using a Tensor 27 FTIR microscope (Bruker Optics, Ltd.) with 2cm-1 resolution over the 
range of 600-2000cm-1. Each spectrum presented in this study is the result of 500 repetitive scans. 
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3.2.6 Electrochemical Measurements 
      Electrochemical measurements were carried out in a conventional one-compartment cell with 
a CHI650A Potentiostat (CH Instruments Inc., Austin, TX) at ambient temperature (20±2°C). 
All potentials were measured against a Ag/AgCl reference electrode (Bioanalytical Systems, 
West Lafayette, IN), and the counter electrode was a platinum wire. All scans were started at the 
negative end of the potential range and proceeded in the positive direction. For the 
chronoamperometric experiments, a constant potential of +0.45mV against saturated Ag/AgCl 
was applied. 
3.3 Results and Discussion 
3.3.1 Self-assembly of EFK16-II on the HOPG electrode surface 
      Peptide self-assembly on the HOPG electrode surface was investigated by atomic force 
microscopy. Figure 3.2a and b show images of surfaces of a bare HOPG and an EFK16-II 
modified HOPG, respectively. Peptide nanofibres were observed on the EFK16-II-modified 
HOPG electrode. This structure is similar to what Yang at al.122 observed in a study of the self-
assembly of another ionic-complementary peptide EAK16-II (sequence: AEAEAKAK-
AEAEAKAK) on HOPG surface. From Figure 3.2b, it can be seen that most of the HOPG 
surface was covered by EFK16-II nanofibres. One of the advantages of ionic-complementary 
peptide for surface modification is that the modification process is quite simple, involving only 
the immersion of the substrate in an aqueous peptide solution. The adsorption of EFK16-II on 
HOPG surface is likely due to hydrophobic interactions. The ionic-complementary peptide has an 
amphiphilic structure. As shown in Figure 3.1, the upper side residues of the peptide are 
hydrophilic and the lower side residues are hydrophobic. When in contact with a hydrophobic 
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surface (e.g. HOPG), the peptide tends to orient itself so that the hydrophobic residue 
phenylalanine will face the hydrophobic HOPG surface. On the other hand, the hydrophilic 
residues glutamic acid and lysine will face the opposite direction, which is towards the solution 
phase covering the HOPG surface. A high coverage of the peptide nanofibres and orientation of 
glutamic acid residues make EFK16-II-modified HOPG electrodes a perfect platform for enzyme 
immobilization.  
 
               
 
Figure 3.2 Tapping mode AFM images of a bare HOPG surface (a) and EFK16-II modified 
HOPG surface (b). The scan scale is 6μm×6μm. 
 
 
3.3.2 Chemistry in Enzyme Immobilization 
      Carboxyl groups of the glutamic acid residues on the ionic complementary peptide participate 
in enzyme immobilization. These were used to covalently link amine groups from GOx. Fewer 
available carboxyl groups on the HOPG electrode surface lead to less immobilized GOx. The 
(a) (b) 
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method introduced by Yang et al121 (the first method) has the problem that carboxyl groups can 
be consumed by amine groups on nearby lysine residues in the peptide. After a carboxyl group is 
activated by forming a sulfo-NHS ester, which is susceptible to attack by amines, nearby amine 
groups from lysine residues of the peptide are likely to react with this ester and form an amide 
bond. Over a 1-hour activation period, the peptide side chains are likely to cross-link so that few 
carboxyl groups survive for enzyme immobilization. This process is shown in Figure 3.3a. 
       On the contrary, the second immobilization method, which is recommended in this study, 
inhibits peptide cross-linking by avoiding the activation period. A mixed solution of GOx, EDC 
and sulfo-NHS was injected onto the EFK16-II modified HOPG electrode surface directly. More 
active enzyme molecules can be immobilized onto the electrode surface because fewer peptide 
carboxyl groups react with amine groups of the peptide. In addition, GOx also has carboxyl 
groups on its surface; GOx carboxyls could be activated in the solution containing EDC and 
sulfo-NHS and react with amine groups of the peptide. This can also contribute to improved 
active GOx immobilization. The process is shown in Figure 3.3b. 
      The above ideas are supported by both FTIR results and electrochemical measurements. 
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Figure 3.3 Schemes for enzyme immobilization: the black solid rectangles denote the EFK16-II 
modified HOPG electrode; (a) the EFK16-II modified HOPG electrode was activated by 2mM 
EDC and 5mM NHS for 1h, then it was covered by 1mg/ml GOx solution overnight; (b) the 






















































































































































3.3.3 ATR-FTIR Spectra 
      The ATR-FTIR spectrum of self-assembled EFK16-II on the HOPG surface is presented in 
Figure 3.4(a). The peptide film was then covered by 100μl potassium buffer (pH 5.5) containing 
2mM EDC and 5mM sulfo-NHS for 1h. After that, the surface was washed by Milli-Q water and 
dried for ATR-FTIR measurement. Results are shown in Figure 3.4(b), where a stronger intensity 
of the characteristic peak for the amide group is evident at 1550cm-1 123. This provides supporting 
evidence that the peptide was cross-linked during this period by forming amide bonds. Figure 
3.4(a) shows the N-H deformation vibration peak at 840cm-1 and C-N stretching vibration peak at 
1130cm-1 from primary amines of lysine. However, both of these peaks are absent in Figure 





Figure 3.4 ATR-FTIR spectra of self-assembled EFK16-II on the HOPG surface (a) and cross-






















3.3.4 Electrochemical Comparison of Two Immobilization Methods 
      In order to compare the two methods for enzyme immobilization, electrochemical 
measurements were conducted. Figure 3.5 shows cyclic voltammograms of the GOx-immobilized 
EFK16-II modified HOPG electrode in 0.1M potassium phosphate buffer (pH 7.0) containing 
0.2mM FCA as a mediator124 in the absence and presence of 20mM glucose. In the absence of 
glucose (Figure 3.5a and b), similar CV curves were observed for both the Method 1 GOx 
electrode and Method 2 GOx electrode. In the presence of 20mM glucose (Figure 3.5c and d), the 
Method 2 GOx electrode produces an anodic peak current of 56.0μA while the Method 1 GOx 
electrode yields an anodic peak current of only 16.0μA. A much higher electrocatalytic current 
achieved by the Method 2 GOx electrode suggests that more active GOx molecules were 
immobilized on the electrode surface using the second method. During this immobilization 
process, more GOx molecules maintained their catalytic activity125.  
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Figure 3.5 Cyclic voltammograms in 0.1M potassium phosphate buffer (pH 7.0) containing 
0.2mM FCA: (a) Method 1 GOx electrode without glucose; (b) Method 2 GOx electrode without 
glucose; (c) Method 1 GOx electrode with 20mM glucose; (d) Method 2 GOx electrode with 
20mM glucose. Scan rate is 2mV/s; electrode area is 1cm×1cm. 
 
 
       The performance of these two electrodes was also compared using chronoamerometry. I-t 
curves (Figure 3.6) for the enzyme electrodes were acquired at a constant potential of +0.45V vs. 
Ag/AgCl. Solutions with different concentrations of glucose containing 0.2mM FCA were used. 
For both Method 1 and Method 2 GOx electrodes, steady-state currents were obtained within 
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2min. The steady-state currents increased when the glucose concentration rose from low to high 
before leveling off at high concentration. This behavior is typical for enzyme modified electrodes 
126.  The calibration curves shown in Figure 3.7a were obtained by subtracting the steady-state 
currents with background currents. The curves for both electrodes have a linear range up to 8mM 
glucose. The Method 2 GOx electrode has a sensitivity value of 4.94mA M-1 cm-2, which is 
almost 6 times higher than that of Method 1 GOx electrode (0.84mA M-1 cm-2). The current 
densities of the Method 1 and Method 2 GOx electrodes at 30mM glucose are 49.7μA cm-2 and 
9.4μA cm-2, respectively. The much higher current density for Method 2 GOx electrode is further 
support that more active GOx molecules were immobilized onto the EFK16-II modified HOPG 
electrode surface, when the second immobilization method was used.  
        Results from both sensitivity and saturated current data provide evidence for the hypothesis 
that the carbodiimide agent causes cross-linking between peptide residues, leading to fewer active 






































Figure 3.6 Chronoamperometric i-t curves of Method 1 GOx electrode (a) and Method 2 GOx 
electrode (b) in 0.1M potassium phosphate buffer (pH 7.0) containing 0.2mM FCA and various 









Figure 3.7 Calibration curves of Method 1 and 2 GOx electrodes (a) and linear range of the 




        The stabilities of both Method 1 and Method 2 GOx electrodes were investigated by 
comparing the anodic currents of cyclic voltammograms for 20mM glucose before and after one 
week of storage at 4°C in 100mM potassium phosphate buffer (pH 7.0). The Method 1 GOx 
electrode retained 86% of its original activity, while the Method 2 GOx electrode showed 81% of 
its original value. One possible reason for the good stabilities of these electrodes is that the ionic-
complementary peptide modified HOPG electrodes provide a biocompatible environment for the 
enzyme. 
        The above results not only demonstrate a good method for enhanced active enzyme 
immobilization, but also provide insight into the appropriate design of peptide sequences for 
biosensor applications. Peptide self-assembly is important because this yields a stable structure 
on the HOPG electrode. Lysine residues play a significant role in EFK16-II self-assembly 
because of electrostatic attraction between lysine residues and glutamic acid residues110. On the 
other hand, lysine residues with amine groups appear to be detrimental in terms of enzyme 
immobilization, according to this study. A peptide that contains only carboxyl groups in the side 
chains and forms a stable nanostructure on the electrode surface would be an ideal candidate for 
biosensor applications.  
 
3.4 Conclusions 
     The ionic-complementary peptide EFK16-II was used to modify an HOPG electrode, 
providing a nanofibre structure of the self-assembling peptide on the electrode surface. Carboxyl 
groups from glutamic acid residues were used for immobilization of GOx. However, we found in 
this study that amine groups from lysine residues of EFK16-II can also react with nearby 
carboxyl groups, forming intra- or interpeptide amide bonds and this affects subsequent enzyme 
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immobilization significantly. To overcome this problem, we introduced a simple and 
straightforward method for GOx immobilization. A mixed solution of GOx, EDC and sulfo-NHS 
was injected onto the surface of EFK16-II modified HOPG electrodes. This method inhibited 
cross-linking of the peptide itself and more active GOx molecules were immobilized. A much 
higher current density (49.7μA/cm2 vs. 9.4μA/cm2 at 30mM glucose) and sensitivity (4.94mA M-
1 cm-2 vs. 0.84mA M-1 cm-2) were achieved with this method. The greatly enhanced 
electrochemical performance makes the ionic-complementary peptide modified electrode a 





















     With recent development of nano-bio materials, self-assembling peptides emerge as a new 
class of materials, which have many potential applications in biomedical and pharmaceutical 
areas. These peptides were first found by Zhang et al.127,128 in 1992 from zoutin, a reported Z-
DNA binding protein in yeast. The self-assembling peptides are biocompatible and 
biodegradable.128 These properties make them ideal as matrices in tissue engineering and drug 
delivery.  
Ionic-complementary peptides EAK16-II and RAD 16-II can self-assemble into well-ordered 
nanofibers and porous membranes, with fiber width of 10nm and pore size ranging from 5 to 
200nm.128,129 Their three-dimensional nanofiber structures are similar to natural extracelluar 
matrices such as collagen. These peptides have been used to study cell attachment, survival and 
proliferation.130-132 The peptide scaffolds from RADA16-I and RADA16-II form nanofiber 
scaffolds in physiological solutions that stimulated extensive rat neurite growth, and active 
synapse formation on the peptide surface was successfully achieved.133 
     Peptides also show much potential for drug delivery. The most attractive aspect of peptide-
mediated drug delivery is the natural propensities of many peptides for cell penetration and 
targeting.134-136 As a result, many novel delivery systems involve peptides to achieve targeted 
delivery for anticancer therapeutics and to cross the cell membrane barrier for gene/siRNA 
delivery. In one study, the ionic-complementary peptides EAK16-II was shown to stabilize 
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pyrene microcrystals in an aqueous solution at concentration up to ten thousand times above its 
solubility in water of 7.0×10-7M.137 EAK16-II was investigated to stabilize a hydrophobic 
anticancer agent ellipticine in another study.138 EAK16-II can stabilize two forms ellipticine, 
protonated or crystalline, depending on different combinations of EAK16-II and ellipticine 
concentrations. In addition, the complexes containing protonated ellipticine are found to have a 
better anticancer activity against two cancer cell lines, A549 and MCF-7.  
     Recently, self-assembled nanotubes of the peptide diphenylalanie (FF) have shown potential 
for use in biosensor applications.75,76 Modification of carbon and gold electrodes by these peptide 
nanotubes can improve the reaction reversibility of the Fe(CN)64-/Fe(CN)63- redox couple; it also 
enables these electrodes to exhibit a direct and unmediated response to H2O2 and NADH. In 
addition, glucose oxidase-based biosensors modified by such peptide nanotubes exhibited 
unmediated, rapid response to successive additions of glucose. In another study, an ionic-
complementary peptide EFK16-II was used to modify a graphite electrode.121 It was found that 
the peptide nanofiber coating did not block electron transfer to the electrode. Glucose oxidase 
could be immobilized onto the peptide nanofiber-modified electrode and used as a glucose sensor. 
The linear range between current and glucose concentration extends as far as 7mM. 
In this study, another typical ionic-complementary peptide EAK16-II was investigated for 
biomolecular sensing. The molecular structure of EAK16-II is shown in figure 4.1. EAK16-II 
was used to modify a hydrophobic electrode, highly order pyrolytic graphite (HOPG). This 
EAK16-II modified HOPG electrode was characterized by atomic force microscopy (AFM). The 
redox couple Fe(CN)63-/4- was used as a probe to test the electrochemical properties of the 
modified electrode. This electrode was then further studied in immobilizing different compounds, 
including glucose oxidase (GOx), ferrocene carboxylic acid (FCA) and myoglobin (Mb). This 
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work provides insights into applications of ionic-complementary peptides in bioelectro-analysis. 
Figure 4.1 Molecular structure of EAK16-II (AEAEAKAKAEAEAKAK) 
 
 
4.2 Materials and Methods 
4.2.1 Materials 
     The ionic-complementary peptide AEAEAKAKAEAEAKAK (EAK16-II) was purchased 
from CanPeptide Inc. (Quebec, Canada) and used without further purification. In the peptide 
sequence, F stands for phenylalanine, E stands for glutamic acid and K stands for lysine. The N-
terminus and C-terminus of the peptide were protected by acetyl and amino groups, respectively. 
      Highly ordered pyrolytic graphite (HOPG, 1cm×1cm) was obtained from SPI Supplies 
(West Chester, PA, USA). Glucose oxidase (GOx) from Aspergillus niger, glucose, 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide (EDC), sulfo-N-hydroxysulfosuccinimide (sulfo-NHS), 
ferrocenecarboxylic acid (FCA), K2HPO4, KH2PO4 and Cytochrome c (Cyt c) were all purchased 




4.2.2 Preparation of the Peptide Modified HOPG Electrode 
      A freshly cleaved HOPG electrode was covered with 100μl of 0.2mg/ml EAK16-II stock 
solution and incubated overnight to modify the graphite surface. The electrode surface was then 
washed by Milli-Q water three times to remove loosely attached EFK16-II. The EAK16-II-
modified HOPG electrode was then further modified as described in the following sections. 
 
4.2.3 Atomic Force Microscopy 
      The structure of the peptide-modified HOPG surface was investigated using a PicoScanTM 
AFM (Molecular Imaging, Phoenix, AZ). To prepare the AFM samples, 100μl of 0.5 mg/ml 
EFK16-II stock solution was injected onto a freshly cleaved HOPG surface and incubated for 3h. 
It was then washed 3 times with Milli-Q water and left dry for 1-2 h. Silicon crystal tips (type 
NCL, NanosensorsTM) with a radius of 10nm were used for AFM tapping mode imaging. The 
AFM tip resonance frequency for imaging was between 160 and 180 kHz.  
 
4.2.4 Electrochemical Measurements 
      Electrochemical measurements were carried out in a conventional one-compartment cell with 
a CHI650A Potentiostat (CH Instruments Inc., Austin, TX) at ambient temperature (20±2°C). 
All potentials were measured against a Ag/AgCl reference electrode (Bioanalytical Systems, 
West Lafayette, IN), while the counter electrode was a platinum wire. All scans were started at 
the negative end of the potential range and proceeded in the positive direction. For the 
chronoamperometric experiments, a constant potential of +0.45mV against saturated Ag/AgCl 
was applied. 
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4.3 Results and Discussion 
4.3.1 Characterization of EAK16-II Modified HOPG Electrode 
Self-assembly of EAK16-II on the HOPG electrode surface 
     Peptide self-assembly on the HOPG electrode surface was investigated by atomic force 
microscopy (AFM). Figure 4.2a and b show images of surfaces of a bare HOPG and an EAK16-
II modified HOPG, respectively. Peptide nanofibers were observed on the EAK16-II modified 
electrode. Interestingly, these fibers were arranged in parallel or at 60º or 120º to each other. This 
phenomenon agrees with what Yang et al. observed.122 The formation process has been 
characterized as being surface directed/assisted assembly. Such orientations of the adsorbed 
molecules/nanofibers arise presumably due to the hexagonal crystal structure of the HOPG (0001) 
surface and reflect the importance of substrate-peptide interactions.122 
     EAK16-II molecules have an amphiphilic structure. Thus, the adsorption of these molecules 
onto HOPG surface is likely due to hydrophobic interactions, similar to what was discussed in 
3.3.1. The hydrophobic residues alanine faces the hydrophobic HOPG surface while the 
hydrophilic residues glutamic acid and lysine residues are oriented toward the solution covering 
the HOPG surface. A rich source of functional groups makes this EAK16-II modified HOPG 
electrode a good platform for various biosensing applications. 
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Figure 4.2 Tapping mode AFM images of a bare HOPG surface (a) and EAK16-II modified 
HOPG surface (b). The scan area is 2μm×2μm.  
 
Electrochemical characterization of the EAK16-II modified HOPG electrode 
     The electrochemical properties of EAK16-II modified HOPG electrode were studied by both 
cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS) in a solution 
containing 1.0mM K3Fe(CN)6/K4Fe(CN)6 (1:1). CV is the most common and direct method to 
characterize an electrode. The cyclic voltammograms are shown in Figure 4.3. The peak 
separation ΔEp (ΔEp=Epa-Epc) increased from 92mV for the unmodified electrode to 156mV for 
the EAK16-II modified electrode. An increase in the peak separation indicates that the Fe(CN)63-
/Fe(CN)64- redox couple has become less reversible when the electrode is modified. In addition, 
both anodic and cathodic peak currents slightly decreased upon modification of the electrode. 
The result indicates that after immobilization by EAK16-II, the redox reaction rate of Fe(CN)63-/4- 
(a) (b) 
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at the electrode is reduced slightly. The EAK16-II assembly on the surface slows down the 





















Figure 4.3 Cyclic voltammograms obtained in the presence of 1.0mM K3Fe(CN)6/K4Fe(CN)6 
(1:1) with 0.1M KCl solution on bare HOPG (solid line) and EAK16-II modified HOPG (solid) 
electrodes at a scan speed of 2mV/s.  
 
To further investigate the modification of EAK16-II on the HOPG surface, the impedance 
changes of HOPG and EAK16-II modified HOPG electrode have been studied using 
electrochemical impedance spectroscopy (EIS) in the presence of equimolar Fe(CN)63-/4- (Figure 
4.4). To understand clearly the electrochemical properties of the electrode/solution interfaces, the 
Randle’s equivalent circuit (inset of Figure 4.4) was chosen to fit the obtained impedance data.139 
In Randle’s circuit, it is assumed that the resistance to charge transfer (Rct) and the diffusion 
impedance (W) are both in parallel to the interfacial capacity (Cdl). This parallel combination of 
Rct and Cdl gives rise to a semicircle complex plane plot of –Z” against Z’. The semicircle 
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diameter equals the charge transfer resistance (Rct). This resistance exhibits the electron transfer 
kinetics of the redox-probe at the electrode interface. When HOPG is modified by EAK16-II, the 
diameter of the semicircle increases, indicating the EAK16-II layer hinders the charge transfer. 




















Figure 4.4 Electrochemical impedance spectroscopy of bare HOPG (curve a) and EAK16-II 
modified HOPG electrode (curve b) in the presence of 1.0mM Fe(CN)63-/4- containing 0.1M KCl 
as supporting electrolyte. Inset is the Randle’s equivalent circuit. The electrode area is 1cm×1cm. 
 
4.3.2 Application of EAK16-II Modified HOPG Electrode in Glucose Sensing 
4.3.2.1 Effect of EAK16-II in Glucose Oxidase (GOx) Immobilization 
      In order to investigate the effect of EAK16-II in glucose oxidase (GOx) immobilization, four 
electrodes were prepared. The first electorde is bare HOPG electrode. The second electrode is 
prepared by covering 100μl 1mg/ml GOx on the surface of HOPG and incubating overnight at 




EAK16-II modified HOPG electrode and incubating overnight at 4ºC (HOPG/EAK16-II/GOx). 
The fourth electrode is prepared by activating the EAK16-II modified HOPG with 100μl 50mM 
potassium phosphate buffer (pH 5.5) containing 2mM EDC and 5mM sulfo-NHS for 1h at room 
temperature. This step converts the carboxyl groups into their NHS esters, which is susceptible to 
be attached by amines (Figure 4.5). GOx molecules are then covalently linked to the electrode 
surface by covering 100μl 1mg/ml GOx on this activated surface and incubating overnight at 4ºC 




Figure 4.5 Covalent attachment of the enzyme GOx to the glutamic acid residue of EAK16-II 
using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) and n-hydroxysulfosuccinimide 
(NHS) 
      
      Cyclic voltammetry of these four electrodes was conducted in the 100mM potassium 
phosphate buffer (pH 7.0) containing 0.2mM ferrocenecarboxylic acid (FCA) without (Figure 
4.6a) and with 20mM glucose (Figure 4.6b). Without glucose, the voltammograms of these four 












































four electrodes behaves similarly, although bare HOPG exhibits slightly higher redox peak 
currents. After adding 20mM glucose into the electrolyte, the anodic peak current on bare HOPG 
does not change, since there is no enzyme in this system. The fourth electrode, which has GOx 
molecules covalently linked to EAK16-II modified HOPG, shows the highest anodic peak current, 
indicating that the active enzyme molecules have been efficiently immobilized onto the electrode 
surface by covalent bonding. The enzyme molecules also retain their bio-catalytic activity, 
presumably due to the biocompatibility of the EAK16-II modified HOPG electrode. The third 
electrode, which has GOx molecules physically adsorbed on EAK16-II modified HOPG 
electrode, only has a slightly higher anodic peak current than that of the second electrode, GOx 
molecules physically adsorbed to HOPG. There may be two possible reasons. Firstly, GOx 
molecules have a higher affinity toward EAK16-II than HOPG, so that more GOx molecules are 
adsorbed. Secondly, since EAK16-II provides a biocompatible environment, more of the 



























































Figure 4.6 Cyclic voltammograms of four electrodes (1: HOPG; 2: HOPG/GOx; 3: 
HOPG/EAK16-II/GOx; 4: HOPG/EAK16-II-NH-GOx) obtained in the 100mM potassium 
phosphate buffer (pH 7.0) containing 0.2mM ferrocenecarboxylic acid (FCA) without (a) and 






4.3.2.2 Effect of Intro-/interpeptide Crosslinking 
     Similar to what is discussed in Chapter 3, the effect of intro-/interpeptide crosslinking of 
EAK16-II has also been investigated. Two electrodes were prepared for this purpose. The first 
electrode was prepared in the same way as the fourth electrode described in the previous section. 
It is called Method 1 GOx electrode here. The second electrode was prepared by covering 100μl 
50mM potassium phosphate buffer (pH 5.5) containing 2mM EDC, 5mM sulfo-NHS and 1mg/ml 
GOx and incubating overnight at 4ºC. It is called Method 2 GOx electrode in this study. The 
chemistry involved is discussed in more detail in Chapter 3 and shown in Figure 4.7. It was 
shown in Chapter 3 that amine groups from lysine residues and carboxylic groups from glutamic 
acid residues can form amide bond under the addition of EDC and sulfo-NHS. The same intro-
/interpeptide crosslinking reaction may also occur in the EAK16-II-modified HOPG electrode 
system. In order to explore this question, Method 1 and Method 2 GOx electrodes are prepared 






Figure 4.7 Schemes for enzyme immobilization: the black solid rectangles denote the EAK16-II 
modified HOPG electrode; (a) the EAK16-II modified HOPG electrode was activated by 2mM 
EDC and 5mM NHS for 1h, then it was covered by 1mg/ml GOx solution overnight; (b) the 






















































































































































     The cyclic voltammograms in both cases were obtained in 100mM potassium phosphate 
buffer (pH 7.0) containing 0.2M FCA as the mediator in the presence of 20mM glucose and 
shown in Figure 4.8. It is quite obvious that the anodic peak current obtained with the Method 2 
GOx electrode is much higher than that of Method 1 GOx electrode, indicating that more active 
GOx molecules were immobilized onto the electrode surface using the second method. This is 


















Method 1 Gox electrode
Method 2 Gox electrode
 
Figure 4.8 Cyclic voltammograms in 0.1M potassium phosphare buffer (pH 7.0) containing 
0.2mM FCA and 20mM glucose of Method 1 GOx electrode (blue line) and Method 2 GOx 
electrode (purple line). Scan rate is 2mV/s; electrode area is 1cm×1cm. 
 
    The performance of these two electrodes was also compared by chronoamperometry. I-t curves 
(Figure 4.9a and b) of the enzyme electrodes were acquired at a constant potential of 0.45V 
against the Ag/AgCl reference electrode. Different concentrations of glucose solution containing 
0.2mM FCA as the mediator were used. For both the Method 1 and Method 2 GOx electrodes, 
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steady-state current was obtained within 2min. The steady-state currents increased as the glucose 
concentration rose from low to high before levelling off at high glucose concentration. This is 
typical for enzyme-modified electrodes. 



































Figure 4.9 Chronoamperometric i-t curves of Method 1 GOx electrode (a) and Method 2 GOx 
electrode (b) in 0.1M potassium phosphate buffer (pH 7.0) containing 0.2mM FCA and various 




      The calibration curves shown in Figure 4.10a were obtained by subtracting the steady-state 
currents with background currents. The curves for both electrodes have a linear range up to 8mM 
glucose. Method 2 GOx electrode has a sensitivity value of 2.4mA M-1cm-2, which is 4.5 times 
higher than that of Method 1 GOx electrode (0.53mA M-1cm-2). The current densities of Method 
1 GOx electrode and Method 2 GOx electrode at 30mM glucose were 7.9μA cm-2 and 22.5μA 
cm-2, respectively. The much higher current density for Method 2 GOx electrode is a direct 
indication that more GOx molecules were immobilized onto the EAK16-II modified HOPG 
electrode surface when using the second immobilization method. 
      From comparison of results from Chapter 3 and results reported here, it can be concluded that 
ionic-complementary peptides such as EFK16-II and EAK16-II, can cross-link either intro- or 
intermolecularly after they have self-assembled on a hydrophobic surface, for example, HOPG. 









Figure 4.10 Calibration curves of Method 1 and Method 2 GOx eletrodes (a) and linear range of 





4.3.2.3 Acetylation Effect of Amine Groups of Lysine Residues 
      The results in the previous sections indicate that amine groups from lysine residues are 
detrimental for GOx immobilization. This is due to the reaction between amine and carboxyl 
groups. If amine groups are protected through some organic chemistry, this problem should be 
overcome. In light of this analysis, amine groups were acetylated before GOx immobilization. 
The electrode was prepared by the following procedures. After the HOPG electrode was 
immobilized by EAK16-II, this electrode was totally dried and 500μl 10% acetic anhydride in 
CH2Cl2 was injected onto the electrode surface. After 20min at room temperature, the acetic 
solution was removed by Kimwipes. The electrode was rinsed thoroughly by Milli-Q water. Then, 
100μl 50mM potassium phosphate buffer (pH 5.5) containing 2mM EDC and 5mM NHS was 
injected onto the HOPG electrode surface and incubated at room temperature for 1h. At last, the 
modified electrode was rinsed by Milli-Q water and 100μl 100mM potassium phosphate buffer 
(pH 7.0) containing 1.0mg/ml GOx was injected onto the electrode surface and incubated at 4ºC 
overnight. Another electrode was prepared in the same way without acetylation.  
      Cyclic voltammetry was conducted in 100mM potassium phosphate buffer (pH 7.0) 
containing 0.2mM FCA and 20mM glucose. The result was shown in Figure 4.11. It can be 
observed that the acetylated electrode has a decreased anodic peak current compared with 
unacetylated electrode.  






















Figure 4.11 Cyclic voltammograms of acetylated and unacetylated electrodes in 100mM 
potassium phosphate buffer (pH 7.0) containing 0.2mM FCA and 20mM glucose. Scan rate is 
2mV/s. The electrode area is 1cm×1cm.  
 
     In order to further characterize the electrode, chronoamperometry measurements were also 
conducted (Figure 4.12). The sensitivity for unacetylated electrode is 0.53 mA M-1cm-2 while that 
for acetylated electrode is 0.21 mA M-1cm-2. Both cyclic voltammetry and chronoamperometry 
results indicate that the acetylation process does not help to increase the immobilization of active 
GOx molecules. However, this is unexpected from the previous analysis. One possible reason for 
that is the ionic-complementary peptide, which is immobilized on the HOPG surface, may diffuse 
into the CH2Cl2 during the acetylation process. In this way, less peptide molecules are 















































Figure 4.12 Calibration curves of enzyme electrode with acetylated and unacetylated EAK16-II 
(a) and linear range of the calibration curves (b). The applied potential is +0.45V vs. Ag/AgCl. 






4.3.3 Immobilization of Ferrocene Carboxylic Acid (FCA) onto EAK16-II Modified HOPG 
Electrode 
     Co-immobilization of enzymes and redox mediators onto electrode surfaces has received 
considerable attention.30,118,140,141  In this context, Koid and Yokoyama62 have electrochemically 
characterized an enzyme (GOx) electrode based on a ferrocene containing redox polymer. This 
redox polymer was based on cross-linked polyallylamine with covalently attached ferrocene. 
Such a ferrocene-containing cross-linked polyallylamine has been shown in Figure 4.13.  
 
Figure 4.13 Ferrocene containing cross-linked polyallylamine62 
 
     This study of immobilizing redox mediator onto the polymer backbone encouraged us to 
pursue the application of ionic-complementary peptide in a similar way. As can be seen from 
Figure 4.1, the peptide, EAK16-II, has both amine groups and carboxyl groups on the backbone. 
The amine groups can be used to immobilize the mediator, such as ferrocene carboxylic acid 
(FCA), while the carboxyl groups can be used to immobilize the enzyme. A reagentless biosensor 
can be constructed in this way.  
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     In order to test this idea, FCA was immobilized onto the EAK16-II modified HOPG electrode. 
Enough FCA was dissolved in 50mM potassium phosphate buffer (pH 5.5) to obtain a saturated 
solution. The saturated FCA solution was then activated by 2mM EDC and 5mM sulfo-NHS in 
order to transform the carboxyl groups into their sulfo-NHS esters, which are easy to react with 
amine groups to form amid bonds. 100μl of this activated FCA solution was then injected onto 
the EAK16-II modified HOPG electrode and incubated overnight at 4ºC. The electrode was 
thoroughly washed with pH 7.0 potassium phosphate buffer before conducting the 
electrochemical experiments. Cyclic voltammetry was done using this electrode as the working 
electrode. The result is shown in Figure 4.15. It can be seen that the redox current of immobilized 
FCA decreased dramatically when continually scanning over the range of 0-0.5V. The redox peak 
almost disappeared after 50 cycles at the rate of 50mV/s.  This could be due to two possible 
reasons. First is that although the FCA was immobilized at first, it detached from the electrode 
gradually when a potential is applied at the electrode surface. Second, FCA may be not stable in 
this condition. FCA may decompose during this experiment.  
     Although it might be a good idea to immobilize the mediator onto the electrode along with the 
enzyme, it was not successful with the EAK16-II modified HOPG electrode. Further research is 






Figure 4.14 Cyclic voltammograms of HOPG/EAK16-II/FCA electrode. (a) Two consecutive 
sets of 25 cycles. The red line is the first set and the blue line is the second set. (b) An enlarged 
figured of the second set in (a). Scan rate is 50mV/s. The electrode area is 1cm×1cm. The solid 
arrows denote the scan direction. The dash arrows denote that the peak currents decrease as 
increasing scan cycle numbers. 
(a) 
(b) 
Increasing scan cycle numbers 
Increasing scan cycle numbers 
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4.3.4 Immobilization of Cytochrome c (Cyt c) onto EAK16-II Modified HOPG Electrode 
     The interaction and direct electron transfer between redox proteins and electrode surface are 
of great importance and have been widely investigated during the past few years.49,142,143 
Understanding of these reactions fundamentally can provide a desirable model for studying the 
redox behaviour of the proteins in biological systems, which may elucidate the relationship 
between their structure and biological functions. 
     Cytochrome c (Cyt c) is one of the well-studied redox proteins. The single iron atom in the 
Cyt c molecule alternates between the Fe (II) and Fe (III) oxidation states as it functions in the 
transport of electrons. The purpose of this section is to study the immobilization of Cyt c on an 
EAK16-II-modified electrode and the direct electron transfer. The isoeletric point of Cyt c is 
around 10.2, while that of EAK16-II is 6.3.110 So, at pH 7, Cyt c is positively charged while 
EAK16-II is negatively charged. The electrostatic attraction between Cyt c and EAK16-II may 
enable Cyt c to adsorb onto the EAK16-II modified HOPG electrode.  
     Two electrodes were prepared and compared. The first electrode was prepared by injecting 
100μl 5mM potassium phosphate buffer containing 1mg/ml Cyt c onto HOPG electrode and 
incubating at 4ºC overnight (HOPG/Cyt c). The second electrode was prepared by injecting 100μl 
5mM potassium phosphate buffer containing 1mg/ml Cyt c onto EAK16-II modified HOPG 
electrode and incubating at 4ºC overnight (HOPG/EAK16-II/Cyt c). Figure 4.15 shows the cyclic 
voltammograms of these two electrodes. The redox peaks of Cyt c can be seen on both curves, 
which indicates that active Cyt c molecules have been immobilized onto both electrodes. This 
also indicates that there is direct electron transfer between the iron center of the protein and the 
electrode. The surprising aspect is that there seems to be no big difference in the redox current 
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between these two electrodes. The modification of the electrode with EAK16-II does not help the 
























Figure 4.15 Cyclic voltammograms of HOPG/Cyt c (a) and HOPG/EAK16-II/Cyt c (b) in 5mM 
potassium phosphate buffer (pH 7.3). The scan rate is 2mV/s.  
 
     Similar to glucose oxidase (GOx), Cyt c also has amine groups on its periphery. This makes it 
possible to covalently immobilize Cyt c onto EAK16-II using the same method as for GOx. The 
EAK16-II modified HOPG electrode was first activated by EDC and sulfo-NHS; then 100μl 
5mM potassium phosphate buffer (pH 7.3) containing 1mg/ml Cyt c was injected onto this 
electrode surface and incubated at 4ºC overnight (HOPG/EAK16-II-Cyt c). The cyclic 
voltammogram of this electrode is shown in Figure 4.16 (b). Although the redox peaks of Cyt c 
appear, the redox peak currents are almost the same as HOPG/Cyt c, which indicates that the 
























Figure 4.16 Cyclic voltammograms of HOPG/Cyt c (a) and HOPG/EAK16-II-Cyt c (b) in 5mM 
potassium phosphate buffer (pH 7.3). The scan rate is 2mV/s. 
 
     From theoretical analysis, the EAK16-II-modified HOPG electrode should be a useful 
platform for immobilization of Cyt c, due to the electrostatic interaction between the peptide and 
Cyt c. In addition, EAK16-II molecules are rich in functional groups for covalent bond formation 
between the protein and the peptide. Although this idea has not proven to be successful yet, the 
EAK16-II modified electrode system should be a good candidate for protein immobilization.  
 
4.4 Conclusions 
     The ionic-complementary peptide EAK16-II was used to modify an HOPG electrode. 
Nanofibres of the self-assembling peptide formed on the electrode surface due to hydrophobic 
interactions between the peptide and the HOPG surface. Carboxyl groups from glutamic acid 
residues were used to immobilize GOx. A glucose biosensor with a sensitivity as high as 2.4mA 
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M-1cm-2 was obtained. The linear detection range is from 0 to 8mM glucose. An attempt has also 
been made to immobilize the mediator, ferrocene carboxylic acid (FCA), and a redox protein, 
cytochrome c (Cyt c) onto the EAK16-II modified HOPG electrode. Although these attempts 
were not successful in this study, the EAK16-II modified HOPG platform has potential for 




















Chapter 5 Conclusions and Recommendations 
5.1 Conclusions 
     The ionic-complementary peptide EFK16-II was used to modify an HOPG electrode by 
forming a nanofibre structure of the self-assembling peptide on the electrode surface. Carboxyl 
groups from glutamic acid residues were used to immobilize GOx. However, we found in this 
study that amine groups from lysine residues of EFK16-II can also react with nearby carboxyl 
groups, forming intra- or interpeptide amide bonds and negatively affecting enzyme 
immobilization. To overcome this problem, we introduced a simple and straightforward method 
for GOx immobilization. A mixed solution of GOx, EDC and sulfo-NHS was injected onto the 
surface of EFK16-II modified HOPG electrodes. This method inhibited cross-linking of the 
peptide itself and more active GOx molecules were immobilized. A much higher current density 
(49.7μA/cm2 vs. 9.4μA/cm2 at 30mM glucose) and sensitivity (4.94mAM-1cm-2 vs. 0.84mA M-1 
cm-2) were achieved with this method. The greatly enhanced electrochemical performance makes 
the ionic-complementary peptide modified electrode a promising platform in biosensing 
applications.  
     Another ionic-complementary peptide EAK16-II was also used to modify the HOPG electrode. 
Nanofibre of the sellf-assembling peptide formed on the electrode surface due to hydrophobic 
interactions between the peptide and the HOPG surface. Carboxyl groups from glutamic acid 
residues were used to immobilize GOx. A glucose biosensor with a sensitivity as high as 2.4mA 
M-1cm-2 was obtained. The linear detection range is from 0 to 8mM glucose. An attempt has also 
been made to immobilize the mediator, ferrocene carboxylic acid (FCA), and a redox protein, 
cytochrome c (Cyt c) onto the EAK16-II modified HOPG electrode. Although results obtained so 
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far are not good enough, this EAK16-II modified HOPG platform has potential in immobilizing 
various molecules or proteins.  
 
5.2 Recommendations 
     In order to gain further insight in the application of ionic-complementary peptide in electrode 
modification and biomolicular sensing, research in this area can focus on the following: 
1. A model electrode, highly ordered pyrolytic graphite (HOPG) electrode, was used in this 
study. Further research can be conducted by using other electrode materials such as glassy carbon, 
gold or platinum. The self-assembly of the ionic-complementary peptide on these electrode 
should first be studied. Different types of morphology of peptide assembly may form on different 
electrode surfaces. These different types of peptide modified electrodes can be further 
investigated for use in enzyme or protein immobilization. 
2. Most of the study in the thesis focused on the immobilization of glucose oxidase (GOx) 
and glucose sensing. This ionic-complementary modified electrode platform may be useful in the 
immobilization of other enzymes or proteins. Some recommended enzymes and proteins are: 
uricase, cytochrome c, myoglobin, hemoglobin and horseradish peroxidise. 
3. Three ionic-complementary peptides were studied in the thesis, EFK16-II (Chapter 3), 
EAK16-II (Chapter 4) and EAR16-II (Appendix). Other ionic-complementary peptides may also 
be useful for biosensor applications and may have advantages in terms of sensitivity, stability, 
detection limit or linear detection range. A full list of the family of ionic-complementary is 
shown in Table 2.2. Research in this direction can be pursuited. 
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4. The glucose biosensor in this thesis is similar to the anode in biofuel cell. The work in 
biosensor can be easily extended to biofuel cell applications. Further research can focus on the 























Self-assembly Study of EAR16-II and its Application in Biosensing 
     EAR16-II (sequence: AEAEARARAEAEARAR) is a typical ionic-complementary peptide. It 
has the same charge distribution pattern as EAK16-II, which is ――＋＋――＋＋. The self-
assembly of EAR16-II in aqueous solution was characterized by atomic force microscopy (AFM). 
Two substrates were used in this study, which were mica and highly ordered pyrolytic graphite 
(HOPG), respetively. The samples using these two substrates were prepared in the same way. The 
substrate was first cleaved so as to obtain a new and clean surface. 100μl of 100mM EAK16-II 
stock solution was then injected onto the freshly cleaved surface and incubated for 30min. It was 
then washed 3 times with Milli-Q water and was left dry for 1-2h. Silicon crystal tips (type NCL, 
NanosensorsTM) with a radius of 10nm were used for AFM tapping mode imaging.  
       The AFM images of EAR16-II on mica are shown in Figure A1. Both globular and fibril 
structures of EAR16-II assembly are observed. The diameter of the globular structure is 
160.1±19.6nm, and the height is 3.7±0.4nm; the nanofiber has a height of 1.77±0.11nm and a 





    
 
Figure A1 Tapping mode AFM images of EAR16-II on mica surface. The scan area of (a) and (b) 
is 6μm×6μm. The scan area of (c) is 1μm×1μm.  
 
 
     
 
Figure A2 Tapping mode AFM images of a bare HOPG surface (a) and EAR16-II modified 
HOPG surface. The scan area is 6μm×6μm. 
 
     EAR16-II has also been investigated in the biosensing application similar to EAK16-II and 
EFK16-II. 100μl 100mM EAR16-II was first injected onto a freshly cleaved HOPG electrode 
(a) (b) (c) 
(a) (b) 
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surface. The electrode was then incubated at 4ºC overnight. After that, the electrode was first 
washed 3 times by Milli-Q water to remove loosely attached peptide. 100μl 50mM potassium 
phosphate (pH 5.5) containing 2mM and 5mM sulfo-NHS was then injected onto the electrode. 
After 1h, this electrode was washed again and 100μl 100mM potassium phosphate buffer (pH 7.0) 
containing 1.0mg/ml glucose was injected onto the electrode surface and incubated at 4ºC 
overnight (HOPG/EAR16-II/GOx). Cyclic voltammetry measurements were done using this 
modified electrode (HOPG/EAR16-II/GOx) as the working electrode. The result is shown in 
Figure A3. The anodic currents for modified electrode and unmodified electrode are almost the 
same, which suggests that very few active GOx molecules have been immobilized on the 
electrode surface. This may be because of the nanostructure of EAR16-II assembly on HOPG 
surface. It can be seen from Figure A2 that EAR16-II forms globular structure rather than fibril 
structure as EAK16-II and EFK16-II. The functional groups may be enclosed deep inside the 
























Figure A3 Cyclic voltammograms of bare HOPG electrode and HOPG/EAR16-II/GOx in 
100mM potassium phosphate buffer containing 20mM glucose and 0.2mM FCA. The scan speed 
is 2mV/s. Electrode area is 1cm×1cm.  
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